A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/40 (2006.01) A61K 31/00 (2006.01)
Patent
CA 2323173
A method for treating asthma and disease conditions associated therewith is disclosed, particularly using the isozyme selective PKC inhibitor, (S)-3,4- [N,N'-1,1'-((2"-ethoxy)-3"'(O)-4"'-(N,N-dimethylamino)-butane)-bis-(3,3'- indoly1)]-1(H)-pyrrole-2,5-dione and its pharmaceutically acceptable salts.
Cette invention se rapporte à un procédé de traitement de l'asthme et des états pathologiques associés à l'asthme, notamment à l'aide de l'inhibiteur de protéine-kinase C (PKC) à sélectivité pour les isozymes, (S)-3,4-[N,N'-1,1'-((2"-éthoxy)-3'''(O)-4'''-(N,N-diméthylamino)-butane)-bis-(3,3'-indolyl)]-1(H)-pyrrole-2,5-dione et ses sels acceptables sur le plan pharmaceutique.
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Use of pkc-inhibitors for the manufacture of a medicament... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of pkc-inhibitors for the manufacture of a medicament..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of pkc-inhibitors for the manufacture of a medicament... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1444413